SCHEMBL4894515

SCHEMBL4894515

CCN(c1ccc(OCc2cccc(C)c2C)cc1)S(=O)(=O)c1cc(C)c(C)c(C(=O)O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.45
ALDH1A1 P00352 2/20 0.45
HPGD P15428 1/20 0.45
ALOX15 P16050 1/20 0.45
HSD17B10 Q99714 1/20 0.45
ESR1 P03372 5/20 0.43
TSHR P16473 1/20 0.42
KEAP1 Q14145 2/20 0.40
NFE2L2 Q16236 2/20 0.40
NSD2 O96028 1/20 0.39
POLB P06746 1/20 0.39
APEX1 P27695 1/20 0.39
RECQL P46063 1/20 0.39
ESR2 Q92731 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KMT2A Q03164 1/20 0.39
FFAR1 O14842 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4900687 0.91 ESR1 (0.39) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4907273 0.90 LMNA (0.49) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4907012 0.89 LMNA (0.49) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4906732 0.83 LMNA (0.47) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4897627 0.83 KEAP1 (0.48) LMNAHSD17B10TSHRKEAP1NFE2L2
SCHEMBL4903991 0.83 LMNA (0.54) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4906452 0.82 ALDH1A1 (0.41) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4907053 0.82 LMNA (0.48) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4906496 0.81 LMNA (0.51) LMNAALDH1A1HPGDALOX15HSD17B10
SCHEMBL4897727 0.80 MMP2 (0.48) LMNAKEAP1NFE2L2POLBFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds HAMANAKA ERNEST S 2006-10-12 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229363-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARA, PPARG, PPARD LMNA 317/4885ALDH1A1 2664/4885HPGD 696/4885
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HPGD 724/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885ALDH1A1 2956/4885HPGD 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.